Evaluation of in-house genotyping assay performance using dried blood spot specimens in the global world health organization laboratory network

Clinical Infectious Diseases

Volumn 54, Issue SUPPL. 4, 2012, Pages

  Parkin, Neil ^a   De Mendoza, Carmen ^b   Schuurman, Rob ^c   Jennings, Cheryl ^d   Bremer, James ^d   Jordan, Michael R ^e   Bertagnolio, Silvia ^e   Brooks, James ^f   Sandstrom, Paul ^f   Wagar, Nicholas ^g   Yang, Chunfu ^g   Mouacha, Fatima ^h   Peeters, Martine ^h   Pinson, Patricia ⁱ   Fleury, Herve ⁱ   Hearps, Anna ^j   Crowe, Suzanne ^j   Yamamura, Yasuhiro ^k   Cane, Pat ^l   Ledwaba, Johanna ^m   Morris, Lynn ^m   Cunningham, Philip ⁿ   Aghokeng, Avelin ^o   Tripathy, Srikanth ^p   Paranjape, R S ^p   Zeh, Clement ^q   Dos Santos, Georges ^r   Stevens, Wendy ^s   Toure Kane, Coumba ^t   more..

^a DATA FIRST CONSULTING INC   (United States)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

ⁱ BORDEAUX UNIVERSITY HOSPITAL   (France)

^j BURNET INSTITUTE   (Australia)

^k AIDS Research Program Immunology Reference Laboratory   (Puerto Rico)

^l PUBLIC HEALTH ENGLAND   (United Kingdom)

^m NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

ⁿ State Reference Laboratory for HIV   (Australia)

^o Institut de Recherche pour le Developpement Cameroon   (Cameroon)

^p NATIONAL AIDS RESEARCH INSTITUTE   (India)

^q KEMRI CDC HIV Research Laboratory   (Kenya)

^r Centre Hospitalier et Universitaire de Fort de France   (France)

^s CLS Genotyping Laboratory   (South Africa)

^t Bacteriology Virology UTH A Le Dantec   (Senegal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; ENVIRONMENTAL TEMPERATURE; GENOTYPING TECHNIQUE; GOOD LABORATORY PRACTICE; NUCLEOTIDE SEQUENCE; PLASMA; PRIORITY JOURNAL; REPRODUCIBILITY; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

EID: 84860360470     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir982     Document Type: Article

References (14)

1. World Health Organization. Joint United Nations Program on HIV/AIDS, UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva, Switzerland: World Health Organization, 2010. Available at: http://www.who. int/hiv/pub/2010progressreport/en/index.html. Accessed 5 July 2011.
2. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther 2008; 13(Suppl 2):1-13. (Pubitemid 352019085)
3. Bertagnolio S, Derdelinckx I, ParkerM, et al. WorldHealthOrganization/ HIVResNet drug resistance laboratory strategy. Antivir Ther 2008; 13(Suppl 2):49-57. (Pubitemid 352019089)
4. Bertagnolio S, Parkin NT, Jordan M, Brooks J, Garcia-Lerma JG. Dried blood spots for HIV-1 drug resistance and viral load testing: a review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev 2010; 12:195-208.
5. Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther 2009; 14:619-29.
6. Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokineinduced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238:800-2.
7. Huang DD, Bremer JW, Brambilla DJ, et al. Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assays. J Clin Microbiol 2005; 43:3963-70. (Pubitemid 41129687)
8. Johnson VA, Brun-Vezinet F, Clotet B, et al. Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med 2010; 18: 156-63.
9. Huang DD, Eshleman SH, Brambilla DJ, Palumbo PE, Bremer JW. Evaluation of the editing process in human immunodeficiency virus type 1 genotyping. J Clin Microbiol 2003; 41:3265-72. (Pubitemid 36842332)
10. Parkin N, Bremer J, Bertagnolio S. Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010. Clin Infect Dis 2012; 54(Suppl 4):S266-72.
11. Galli RA, Sattha B, Wynhoven B, O'Shaughnessy MV, Harrigan PR. Sources and magnitude of intralaboratory variability in a sequencebased genotypic assay for human immunodeficiency virus type 1 drug resistance. J Clin Microbiol 2003; 41:2900-7. (Pubitemid 36842277)
12. World Health Organization. WHO manual for HIV drug resistance testing using dried blood spot specimens. 2010. Available at: http://www.\who.int/ entity/hiv/topics/drugresistance/dbs-protocol.pdf.Accessed 15 December 2010.
13. McNulty A, Jennings C, Bennett D, et al. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J Clin Microbiol 2007; 45:517-21.
14. Monleau M, Montavon C, Laurent C, et al. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. J Clin Microbiol 2009; 47:1107-18.